Creating CAR T-cell therapies for T-cell malignanciesApril 16, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncologyRare Diseases
Novel CAR T, anti-PD-1 combo shows promise in MPDApril 16, 2019Immuno-oncologyBreast CancerLung Cancer
Pooled KEYNOTE data support pembro for elderly patients with NSCLCApril 12, 2019Lung CancerImmuno-oncology
Dr. Louis Weiner: AACR presentations highlight new “transformative strategies”April 11, 2019Immuno-oncologyLymphoma & Plasma Cell Disorders
Preclinical findings highlight value of Lynch syndrome for cancer vaccine developmentApril 8, 2019GastroenterologyImmuno-oncologyGastrointestinal Cancer
CAR T cells target HER2 expression in advanced sarcomasApril 1, 2019Sarcoma & GISTImmuno-oncologyRare Diseases
Combo may improve PFS, OS for certain ovarian cancer patientsMarch 18, 2019Gynecologic CancerImmuno-oncology
Novel immunostimulant combo shows early efficacyMarch 12, 2019MelanomaImmuno-oncologyBreast CancerSarcoma & GIST
Antibiotics gut checkpoint inhibitor efficacyMarch 12, 2019Immuno-oncologyHead & Neck/Thyroid CancersLung CancerMelanoma
Pembrolizumab/lenvatinib active against urothelial carcinomaMarch 11, 2019Genitourinary CancerImmuno-oncology
Higher dose of checkpoint inhibitor every 4 weeks feasible in NSCLCMarch 7, 2019Lung CancerImmuno-oncologyImmunotherapy
Diet appears to play an important role in response to anti-PD-1 cancer immunotherapyMarch 1, 2019Immuno-oncologyMelanomaPatient & Survivor Care
Barriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyGene Therapy
